This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Maximum Diagnostic Mass of [18Fluor]AZD4694
and you are
between 50 and 85
years old
This is an early phase trial to determine
the dosage and safety of the new treatment.
Show me locations

The purpose

In this study different mass of the radioligand AZD4694 will be given to patients with Alzheimer's Disease and healthy volunteers to evaluate wich Mass of AZD4694 that gives the best opportunities for following disease progress and treatment effects.

Provided treatments

  • Other: [18Fluor]AZD4694
  • Other: [18Fluor]AZD4694
  • Other: [18Fluor]AZD4694

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT01325402. The sponsor of the trial is AstraZeneca and it is looking for 16 volunteers for the current phase.
Official trial title:
Open-Label Positron Emission Tomography Study With Selective Beta Amyloid Radioligand (18Fluor)AZD4694 to Assess the Effects of Varying Mass of AZD4694 on Radioligand Binding Parameters in Healthy Volunteers and Patients With Alzheimer's Disease